HOME >> BIOLOGY >> NEWS
Jefferson scientists use gene therapy to restore function of damaged heart cells in lab

Researchers at Jefferson Medical College and Duke University have used gene therapy to help damaged heart cells regain strength and beat normally again in the laboratory. The work takes the scientists one step closer to eventual clinical trials in humans.

Walter Koch, Ph.D., director of the Center for Translational Medicine of the Department of Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his colleagues at Duke used a virus to carry a gene into the heart cells of individuals who had suffered from congestive heart failure. The gene introduced into these heart cells blocks the activity of an enzyme that is increased in failing human hearts and which contributes to the loss of the heart's contractile strength during the development of heart failure. When the activity of this enzyme is blocked by the gene therapy, the heart cells were able to contract at normal strength and their overall performance was improved.

Dr. Koch and his co-workers at Duke University Medical Center in Durham, N.C., report their findings April 6, 2004, in Circulation, a journal of the American Heart Association.

According to Dr. Koch, who is W.W. Smith Professor of Medicine at Jefferson Medical College of Thomas Jefferson University, researchers have known for some time that the beta-adrenergic receptor system fails to work properly in individuals with congestive heart failure. Such receptors "drive the heart both by rate and force of contraction," he says.

The researchers' target has been the beta-adrenergic kinase (ARK1), an enzyme that is elevated in human heart failure. One of its functions is to turn off beta-adrenergic receptors. "In heart failure, beta adrenergic receptor density is decreased, ARK is increased and both together cause dysfunctional beta receptor signaling," Dr. Koch says. "A failing heart then has little capacity to respond to exercise or stress because there are fewer receptors and the remaining rec
'"/>


5-Apr-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... BARBARA, Calif. (PRWEB) , ... August 30, 2018 , ... ... optimization firm for the life sciences and healthcare industries, has received the 2018 Services ... management. The award was presented by Box SVP of Business Development and Platform Sales, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, founder ... recognizes women of excellence in the field of intellectual property, and named Daniela ... Women in IP Award aims to encourage and support women in their pursuit ...
(Date:8/29/2018)... (PRWEB) , ... August 29, ... ... study validates first non-invasive technology to identify specific chromosomal abnormalities using morphological ... Ovation Fertility and Australia-based Life Whisperer suggests that ...
Breaking Biology News(10 mins):
(Date:8/26/2018)... ... August 24, 2018 , ... ExoCoBio Inc., based ... relieves atopic dermatitis and inhibits a variety of inflammatory targets in the journal ... symptoms of mice having severe atopic dermatitis were significantly improved after administration of ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... company specializing in medical device compliance and commercialization, has just released a ... , Written and presented by Dr. Mario Kossmann, ESEP at the 28th ...
(Date:8/17/2018)... Kan. (PRWEB) , ... August 16, 2018 , ... ... research organization (CRO) is pleased to announce the expansion of their team. Dr. ... was hired to launch an innovative large molecule LC-MS/MS group that will specialize ...
(Date:8/14/2018)... ... August 13, 2018 , ... Labconco Corporation manufactures ... safety cabinets. In addition, Labconco produces other lab equipment, such as glassware washers ... to quality and consistency in design and manufacturing. , Through this webinar, ...
Breaking Biology Technology:
Cached News: